Grifols established the GHAGA program to encourage healthcare professionals, hemophilia treatment centers and hemophilia societies to submit proposals aimed at enhancing education, supporting outreach efforts, strengthening diagnosis and facilitating access to treatment.
The nine GHAGA recipients across the two editions are to be commended for their outstanding initiatives.
GHAGA Award Recipients 2020-2021
In the program’s second edition, five (5) awards up to €30,000 each were offered to participants whose proposals best aligned with the program's objectives, and met all the selection criteria evaluated by an external review committee.
Here you can meet the winners:
“Increased Diagnosis of Bleeding Disorder Using Self-Screening Pediatric Bleeding Assessment Tool Mobile Application (Pediatric-BAT) in Community”
“Android OS-Based Smartphone Application for Hemophilia Self Screening Tool in Kalimantan, Indonesia”
“Hemophilia carriers' status, diagnosis, and counselling in the families of hemophilia Foundation MDQ”
“Affordable & accessible diagnosis project”
“Improve education, and home therapy in hemophilia”
2020-2021 Award recipients
GHAGA Award Recipients 2019-2020
In the program’s first edition, four awards of up to €50,000 each were given to the winning proposals that best matched the GHAGA’s objectives and the selection criteria as assessed by an external review committee.
Here you can meet the awardees:
“Multicenter study of diagnostic tool for patients with hereditary bleeding disorders: from bedside to comprehensive investigation.”
“Strengthen, and standardize Haemophilia diagnosis in Nigeria (Diagnosis Haemophilia Nigeria Project).”
“Comprehensive medical care mobile team.”
“Using mobile application to improve hemophilia care in Yogyakarta, Indonesia.”
2019-2020 Award recipients
Unterstützung der Patienten
Die Patienten, denen wir weltweit helfen, können ein besseres Leben führen. Sie inspirieren unsere Arbeit jeden Tag.
Scientific Awards and Programs
We support the scientific community, and its efforts to improve therapeutic options for patients through scientific awards, scholarships, research sponsorship programs, and a peer-reviewed publication.